Skip to content

Effect of Oral Lactate Ingestion on Appetite Regulation

Effect of Oral Lactate Ingestion on Appetite Regulation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06379815
Enrollment
12
Registered
2024-04-23
Start date
2024-05-01
Completion date
2024-08-31
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetitive Behavior

Keywords

lactate, appetite regulation, acylated ghrelin, energy intake

Brief summary

The goal if this study is to determine how oral lactate ingestion affects markers of appetite regulation. Researchers will compare oral lactate ingestion to a sodium chloride placebo. Participants will consume the lactate or placebo solution and then have blood samples and assessments of appetite over the course of 90 min. Free-living energy intake will be measured for 3 days surrounding each experimental session.

Detailed description

The purpose of this study is to explore the effects of oral lactate ingestion on appetite regulation in humans. To do this males and females will report to the laboratory for 2 experimental sessions completed in a counterbalanced, double-blinded manner. During one session a lactate solution will be ingested, in another session an equimolar sodium chloride solution will be ingested that matches the osmolarity of the lactate condition. Venous blood samples and subjective appetite perceptions will be obtained at five time points during each experimental session. Energy expenditure will be measured through accelerometers placed on the participants anterior thigh by an investigator on the morning the day before the session and worn over the experimental period (day before, day of, day after) recording their physical activity. Energy intake will be tracked using a smartphone mobile application called Keenoa over the same time period the accelerometers are worn.

Interventions

See arm/group description.

OTHERSodium Chloride

See arm/group description.

Sponsors

Natural Sciences and Engineering Research Council, Canada
CollaboratorOTHER
Wilfrid Laurier University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The allocation of lactate and placebo will be completed by a researcher not involved in data collection. Both the participant and the researchers collecting and analyzing the data will be blinded to the treatment allocation. This will be completed in a counter-balanced order.

Intervention model description

Participants will consume a sodium lactate and sodium chloride placebo in a double-blind, crossover design.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Deemed healthy using Canadian Society for Exercise Physiology Get Active Questionnaire * Female participants must be eumenorrheic (menstrual cycle length between 21-35 days)

Exclusion criteria

* Failure to meet inclusion criteria * Taking supplements or medications known to affect metabolism (e.g., creatine, beta-blockers) * Currently pregnant or a pregnancy of \>3 months within the last 3 years,

Design outcomes

Primary

MeasureTime frameDescription
Blood LactatePre-ingestion, 30 minutes following ingestion, 45 minutes following ingestion, 60 minutes following ingestion, and 90minutes following ingestion.Lactate measured in blood.
Acylated ghrelinPre-ingestion, 30 minutes following ingestion, 45 minutes following ingestion, 60 minutes following ingestion, and 90minutes following ingestion.Acylated ghrelin measured in blood via ELISA.
Total ghrelinPre-ingestion, 30 minutes following ingestion, 45 minutes following ingestion, 60 minutes following ingestion, and 90minutes following ingestion.Total ghrelin measured in blood via ELISA.

Secondary

MeasureTime frameDescription
Subjective appetite perceptionPre-ingestion, 30 minutes following ingestion, 45 minutes following ingestion, 60 minutes following ingestion, and 90minutes following ingestion.Measured using visual analogue scale
Free-living energy intakeDay 1 (day before the experimental session), Day 2 (day of the experimental session), and Day 3 (day after the experimental session).Free-living energy intake measured using a mobile application Keenoa

Contacts

Primary ContactTom J Hazell, PhD
thazell@wlu.ca5488893902

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026